About 400 reports

  • 2.2 Human Immunodeficiency Virus (HIV)

ABOUT HIV/ AIDS.

  • Antiviral
  • HIV AIDS
  • World
  • Market Size
  • Gilead Sciences, Inc.

Research and Development Brief Fixed Dose Combination ## for HIV Product Description Fixed dose combination for HIV is under development.

  • HIV AIDS
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

The estimated number of people suffering from HIV in 2015 was recorded to be more than ## million according to AVERT, a UK-based HIV and AIDS charity.

  • HIV AIDS
  • HIV Antiviral
  • Therapy
  • World
  • Forecast

Global HIV/ AIDS Testing Industry I.

  • HIV AIDS
  • Europe
  • Japan
  • World
  • Company Sales
  • SYNTHETIC PEPTIDE FOR HIV/AIDS - DRUG PROFILE
  • VACCINE FOR ONCOLOGY AND HIV/AIDS - DRUG PROFILE
  • Gene Therapy
  • HIV AIDS
  • Pathology
  • United States
  • Merck & Co., Inc.
  • SYNTHETIC PEPTIDE FOR HIV/AIDS - DRUG PROFILE
  • MONOCLONAL ANTIBODIES FOR HIV/AIDS - DRUG PROFILE
  • Cell Therapy
  • HIV AIDS
  • United States
  • Company
  • Product Initiative
  • HIV / AIDS - Dormant Projects
  • HIV / AIDS - Product Development Milestones
  • Gene Therapy
  • HIV AIDS
  • United States
  • Company
  • Product Initiative

Competitive Landscape ##. ## Antigen Express ##. ## Bionor Pharma ##. ## FIT Biotech ##. ## Gilead Sciences ##. ## GeoVax ##. ## GenVec ##. ## Glaxo Smithkline ##. ## Immune Response BioPharma ##. ## Inovio Pharmaceuticals ##. ## Novartis ##. ## Sanofi Pasteur List of Figures Figure ##-##: People Living With HIV Infection

  • HIV AIDS
  • Pathology
  • World
  • JAN 26, 2016: HIV PROTEIN MANIPULATES HUNDREDS OF HUMAN GENES TO ADVANCE PROGRESSION INTO AIDS, STUDY SHOWS

D' Orso said, describing the situation in which HIV infection leads to AIDS.

  • Cancer
  • Healthcare
  • HIV AIDS
  • Specialty Hospital
  • GlobalData's company

REASONS FOR DOING THE STUDY HIV/ AIDS is one of the most catastrophic threats to human health throughout the world.

  • HIV AIDS
  • Pathology
  • World
  • HIV / AIDS - Dormant Projects
  • HIV / AIDS - Recent Pipeline Updates
  • Gene Therapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Gilead Sciences, Inc.
  • Month & Year
  • CHINA DOMINATED THE ASIAN HIV DIAGNOSTICS MARKET IN 2016
  • HIV AIDS
  • HIV Diagnostic
  • World
  • Market Size
  • Roche Group
  • Jun 07, 2016: NIH Awards Emory $35.6 Million Grant for Research Aimed at HIV/AIDS Vaccine and Cure
  • HIV AIDS
  • Pharmaceutical
  • Therapy
  • United States
  • GlobalData's company
  • 9.9 HIV/AIDS
  • IVD MARKET SIZE FOR HIV/AIDS, BY COUNTRY, 2015-2022 (USD MILLION)
  • HIV AIDS
  • Asia
  • Forecast
  • Market Size
  • Roche Group
  • PIPELINE BY MYMETICS CORP, H2 2017
  • PIPELINE BY INNAVIRVAX SA, H2 2017
  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Mymetics Corporation
  • Apr 19, 2016: ABIVAX Obtains Regulatory and Ethics Clearance in Spain to Begin Second Phase IIa Clinical Trial For ABX464 In HIV/AIDS Patients
  • 10/11/2016: ABIVAX Announces R&D Day at Company's New Collaborative Laboratory in Montpellier
  • HIV AIDS
  • Infectious Disease
  • Therapy
  • France
  • ABIVAX
  • Trans Activator Of Transcription (Tat) - Dormant Projects
  • Products under Investigation by Universities/Institutes, H2 2016
  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Cannabis Science, Inc.
  • PIPELINE BY CALIMMUNE, INC., H2 2016
  • DORMANT PROJECTS (CONTD..1), H2 2016
  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Tobira Therapeutics, Inc.
  • DORMANT PRODUCTS, H1 2018 (CONTD..1), H1 2018
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H1 2018
  • HIV AIDS
  • Pathology
  • Therapy
  • United States
  • CytoDyn Inc.
  • WESTERN BLOTTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND
  • Untitled
  • HIV AIDS
  • Asia
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H2 2017
  • PIPELINE BY PHARIS BIOTEC GMBH, H2 2017
  • HIV AIDS
  • Pathology
  • Therapy
  • United States
  • Product Initiative
  • Pipeline by Akshaya Bio Inc., H1 2016
  • Trans-Activator Of Transcription (Tat) - Dormant Projects
  • HIV AIDS
  • Vaccine
  • World
  • Product Initiative
  • Cannabis Science, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2016
  • PIPELINE BY VIIV HEALTHCARE LTD, H2 2016
  • Antiviral
  • HIV AIDS
  • United States
  • Product Initiative
  • ViiV Healthcare Ltd.
  • Human Immunodeficiency Virus (HIV) Infections (AIDS)
  • Human Immunodeficiency Virus (HIV) Infections (AIDS)
  • HIV AIDS
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative
  • DEAL TYPE
  • DEAL TYPE

(also Benitec Biopharma Limited), a biotechnology company, entered into a licensing agreement with Calimmune, Inc., a developer of stem cell HIV/ AIDS therapy, for the use of directed RNA interference (ddRNAi) technology in the area of HIV/ AIDS.

  • HIV AIDS
  • Therapy
  • United States
  • Company
  • Benitec Biopharma Limited
  • Human Immunodeficiency Virus (HIV) Infections (AIDS)
  • Do not have: cervical esophageal carcinoma, known or suspected autoimmune disease, HIV, or AIDS
  • Cancer
  • Cancer Immunotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Merck & Co., Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2016
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016
  • HIV AIDS
  • Vaccine
  • United States
  • Product Initiative
  • GeoVax Labs, Inc.
  • Biotron Ltd - Opportunities
  • Biotron Ltd, History
  • HIV AIDS
  • Australia
  • United States
  • Company Financials
  • Biotron Limited
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H2 2016
  • PIPELINE BY VIIV HEALTHCARE LIMITED, H2 2016
  • HIV AIDS
  • Therapy
  • Vaccine
  • United States
  • Product Initiative
  • ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • GLOBAL INCIDENCE OF CANCER

According to UNAIDS' HIV and AIDS estimates in 2015, the number of people living with HIV in Italy was reported as ##, ##.

  • HIV AIDS
  • Europe
  • Forecast
  • Market Size
  • Roche Group